Mersana Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Mersana Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 39% to $36,855,000. The net income raised on -$171,670,000 and profit margin reached -466%. Total operating expenses were $36,855,000.
Profit Margin
| 2015 | 10.35M | -16.42M | -158.59% |
|---|---|---|---|
| 2016 | 25.17M | -13.7M | -54.43% |
| 2017 | 17.54M | -38.70M | -220.62% |
| 2018 | 10.59M | -64.25M | -606.54% |
| 2019 | 42.12M | -27.19M | -64.57% |
| 2020 | 828K | -88.40M | -10676.81% |
| 2021 | 43K | -169.20M | -393500% |
| 2022 | 26.58M | -207.54M | -780.78% |
| 2023 | 36.85M | -171.67M | -465.8% |
MRSN Income Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Revenue | 36.85M | 26.58M | 43K | 828K | 42.12M | 10.59M | 17.54M | 25.17M | 10.35M |
Cost of revenue | 148.26M | 927K | 132.01M | 67.03M | 55.04M | 0 | 928K | 0 | 21.35M |
Gross profit | -111.41M | 25.65M | -131.97M | -66.20M | -12.91M | 10.59M | 16.61M | 25.17M | -10.99M |
Operating exp. | |||||||||
Research and development | 148.26M | 173.38M | 132.01M | 67.03M | 55.04M | 59.91M | 46.7M | 32.00M | 21.35M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 36.85M | 230.34M | 168.90M | 88.93M | 72.32M | 76.24M | 57.16M | 38.99M | 26.7M |
Operating income | -170.95M | -204.69M | -169.71M | -87.68M | -29.21M | -65.65M | -39.61M | -13.82M | -16.34M |
Other income (expenses), net | -713K | 482K | -347K | 65K | 1.01M | 1.39M | 910K | 121K | -87K |
Income before tax | -171.67M | -204.21M | -170.06M | -88.04M | -28.20M | -64.25M | -38.70M | -13.7M | -16.42M |
Income tax expense | 0 | 3.32M | -855K | 359K | -1.01M | 1.39M | 0 | 0 | -2K |
Net income | -171.67M | -207.54M | -169.20M | -88.40M | -27.19M | -64.25M | -38.70M | -13.7M | -16.42M |
Earnings per share | |||||||||
Basic EPS | -1.48 | -2.22 | -2.4 | -1.44 | -0.63 | -2.79 | -3.22 | -0.78 | -0.94 |
Diluted EPS | -1.48 | -2.22 | -2.4 | -1.44 | -0.63 | -2.79 | -3.22 | -0.78 | -0.94 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |